ImmuneSense™ COVID-19 Study

Clinical trial NCT04583982 · COMPLETED

Trial details

NCT number: NCT04583982
Sponsor: Adaptive Biotechnologies
Status: COMPLETED
Study type: OBSERVATIONAL

Coronavirus Disease (COVID-19)SARS-CoV-2 Infection

Start date: 2020-10-09
Primary completion: 2020-12-04
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.